Insights into the antibacterial mechanism of PEGylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillin-resistant strains [Corrigendum]
Insights into the antibacterial mechanism of PEG ylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillinresistant strains [Corrigendum]
Hong W, Liu L, Zhang Z, Zhao Y, Zhang D, Liu M. Int J Nanomedicine. 2018;13:6297–6309.
The author wishes to advise that on page 6306, Figure 7 parts A and B are incorrect. The correct figure parts are included below:
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.